These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 25964531)

  • 41. Association between polymorphisms in cell cycle genes and advanced prostate carcinoma.
    Kibel AS; Jin CH; Klim A; Luly J; A Roehl K; Wu WS; Suarez BK
    Prostate; 2008 Aug; 68(11):1179-86. PubMed ID: 18459109
    [TBL] [Abstract][Full Text] [Related]  

  • 42. COX-2 promoter polymorphisms and the association with prostate cancer risk in South African men.
    Fernandez P; de Beer PM; van der Merwe L; Heyns CF
    Carcinogenesis; 2008 Dec; 29(12):2347-50. PubMed ID: 18974063
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A large prospective study of SEP15 genetic variation, interaction with plasma selenium levels, and prostate cancer risk and survival.
    Penney KL; Schumacher FR; Li H; Kraft P; Morris JS; Kurth T; Mucci LA; Hunter DJ; Kantoff PW; Stampfer MJ; Ma J
    Cancer Prev Res (Phila); 2010 May; 3(5):604-10. PubMed ID: 20424130
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polymorphisms in CRYBB2 encoding βB2-crystallin are associated with antisaccade performance and memory function.
    Giegling I; Hartmann AM; Genius J; Konte B; Maul S; Straube A; Eggert T; Mulert C; Leicht G; Karch S; Hegerl U; Pogarell O; Hölter SM; Möller HJ; Graw J; Rujescu D
    Transl Psychiatry; 2020 Apr; 10(1):113. PubMed ID: 32317624
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of FOXP4 Gene with Prostate Cancer and the Cumulative Effects of rs4714476 and 8q24 in Chinese Men.
    Liu M; Shi X; Wang J; Xu Y; Wei D; Zhang Y; Yang K; Wang X; Liang S; Chen X; Yang F; Sun L; Zhu X; Zhao C; Zhu L; Tang L; Zheng C; Yang Z
    Clin Lab; 2015; 61(10):1491-9. PubMed ID: 26642711
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic variants in epithelial-mesenchymal transition genes as predictors of clinical outcomes in localized prostate cancer.
    Deng Y; Xie K; Logothetis CJ; Thompson TC; Kim J; Huang M; Chang DW; Gu J; Wu X; Ye Y
    Carcinogenesis; 2020 Aug; 41(8):1057-1064. PubMed ID: 32215555
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of gene polymorphisms of KLK3 and prostate cancer: A meta-analysis.
    Li H; Fei X; Shen Y; Wu Z
    Adv Clin Exp Med; 2020 Aug; 29(8):1001-1009. PubMed ID: 32869960
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tobacco smoking, polymorphisms in carcinogen metabolism enzyme genes, and risk of localized and advanced prostate cancer: results from the California Collaborative Prostate Cancer Study.
    Shahabi A; Corral R; Catsburg C; Joshi AD; Kim A; Lewinger JP; Koo J; John EM; Ingles SA; Stern MC
    Cancer Med; 2014 Dec; 3(6):1644-55. PubMed ID: 25355624
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival.
    Nguyen PL; Ma J; Chavarro JE; Freedman ML; Lis R; Fedele G; Fiore C; Qiu W; Fiorentino M; Finn S; Penney KL; Eisenstein A; Schumacher FR; Mucci LA; Stampfer MJ; Giovannucci E; Loda M
    J Clin Oncol; 2010 Sep; 28(25):3958-64. PubMed ID: 20679621
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A haplotype at chromosome Xq27.2 confers susceptibility to prostate cancer.
    Yaspan BL; McReynolds KM; Elmore JB; Breyer JP; Bradley KM; Smith JR
    Hum Genet; 2008 May; 123(4):379-86. PubMed ID: 18350320
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Toll-like receptor signaling pathway variants and prostate cancer mortality.
    Stark JR; Wiklund F; Grönberg H; Schumacher F; Sinnott JA; Stampfer MJ; Mucci LA; Kraft P
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1859-63. PubMed ID: 19505919
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Insulin-like growth factor-1 genotypes and haplotypes influence the survival of prostate cancer patients with bone metastasis at initial diagnosis.
    Tsuchiya N; Narita S; Inoue T; Saito M; Numakura K; Huang M; Hatakeyama S; Satoh S; Saito S; Ohyama C; Arai Y; Ogawa O; Habuchi T
    BMC Cancer; 2013 Mar; 13():150. PubMed ID: 23530598
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of Candidate Genetic Polymorphisms in Prostate Cancer: An Overview.
    Salvi S; Conteduca V; Gurioli G; Calistri D; Casadio V; De Giorgi U
    Mol Diagn Ther; 2016 Feb; 20(1):1-12. PubMed ID: 26518421
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Crybb2 associates with Tmsb4X and is crucial for dendrite morphogenesis.
    Sun M; Ahmad N; Zhang R; Graw J
    Biochem Biophys Res Commun; 2018 Sep; 503(1):123-130. PubMed ID: 29864422
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correlation between Genomic Variants and Worldwide Epidemiology of Prostate Cancer.
    Vieira GM; Gellen LPA; da Veiga Borges Leal DF; Pastana LF; Vinagre LWMS; Aquino VT; Fernandes MR; de Assumpção PP; Burbano RMR; Dos Santos SEB; Dos Santos NPC
    Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741800
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Crybb2 coding for βB2-crystallin affects sensorimotor gating and hippocampal function.
    Sun M; Hölter SM; Stepan J; Garrett L; Genius J; Kremmer E; Hrabě de Angelis M; Wurst W; Lie DC; Bally-Cuif L; Eder M; Rujescu D; Graw J
    Mamm Genome; 2013 Oct; 24(9-10):333-48. PubMed ID: 24096375
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of single nucleotide polymorphisms in predicting prostate cancer risk and therapeutic decision making.
    Van den Broeck T; Joniau S; Clinckemalie L; Helsen C; Prekovic S; Spans L; Tosco L; Van Poppel H; Claessens F
    Biomed Res Int; 2014; 2014():627510. PubMed ID: 24701578
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interactions of SNPs in Folate Metabolism Related Genes on Prostate Cancer Aggressiveness in European Americans and African Americans.
    Lin HY; Steck SE; Sarkar I; Fontham ETH; Diekman A; Rogers LJ; Ratliff CT; Bensen JT; Mohler JL; Su LJ
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980585
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chemokine Ligand 5 (CCL5) and chemokine receptor (CCR5) genetic variants and prostate cancer risk among men of African Descent: a case-control study.
    Kidd LR; Jones DZ; Rogers EN; Kidd NC; Beache S; Rudd JE; Ragin C; Jackson M; McFarlane-Anderson N; Tulloch-Reid M; Morrison S; Brock GN; Barve SS; Kimbro KS
    Hered Cancer Clin Pract; 2012 Nov; 10(1):16. PubMed ID: 23168091
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Systematic enrichment analysis of potentially functional regions for 103 prostate cancer risk-associated loci.
    Chen H; Yu H; Wang J; Zhang Z; Gao Z; Chen Z; Lu Y; Liu W; Jiang D; Zheng SL; Wei GH; Issacs WB; Feng J; Xu J
    Prostate; 2015 Sep; 75(12):1264-76. PubMed ID: 26015065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.